Skip to main content

Featured

Avi Lewis Wins Federal NDP Leadership in First-Ballot Victory

Avi Lewis, who was proclaimed as the new leader of the NDP, speaks at the party convention in Winnipeg Sunday, March 29, 2026. Filmmaker and longtime activist Avi Lewis has been elected the new leader of the federal New Democratic Party , securing a decisive first‑ballot win with nearly 40,000 votes out of roughly 71,000 cast . His victory marks a significant shift for the party as grassroots members push for a more unapologetically left‑wing direction.  Lewis’s win signals renewed momentum for the NDP after a difficult federal election year. His campaign championed bold proposals—including expanding public ownership in key sectors—and emphasized rebuilding the party from the ground up. He inherits a party reduced to six seats in the House of Commons and facing internal tensions over energy policy, particularly from Alberta and Saskatchewan NDP leaders who warn his positions could harm workers in their provinces.  In his victory speech at the Winnipeg convention, Lewis call...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment